Arena International has announced that Catherine Ela, Head of Clinical Trials Department, Ministry of Health will be chairing the Outsourcing in Clinical Trials Israel conference which is set to take place in Tel Aviv in March. Returning for its 3rd consecutive year, the must-attend event will cover many key topics areas such as qualifying vendors to enable successful partnerships, developing strategies for successful contract development and managing vendor oversight locally and globally.
Ahead of all interactive sessions and presentations, Catherine Ela will be opening the conference on day one and kick-starting what is promised to be a fantastic two days of learning opportunities and networking for leading senior experts in the industry. Joining Catherine for the 3rd Annual conference will be a number of high profile speakers including:
- Ayelet Levanon, Associate Director, Global Clinical Operations, Johnson & Johnson
- Olivia Mishall, Director Clinical Affairs, V-Wave Medical
- Rachel Teitelbaum, CEO, Hervana Bio
- Dr. Arik Hasson, EVP Research and Development, Kadimastem
- Mark levitt, SVP Clinical Affairs, Immune Pharmaceuticals
- Michal Limor, VP Clinical Development, BioCancell Therapeutics
As the Israeli pharmaceutical industry continues to go from strength to strength and with significant investment and innovations emerging, this highly valuable opportunity to meet face to face with industry leaders and colleagues will allow attendees to optimise clinical trials and assist in future growth plans.
If you are interested in joining the Ministry of Health at OCT Israel and are looking to shape your business strategy for 2017 and beyond visit the website http://www.arena-international.com/octisrael/ and book your place by quoting reference code MK-PR. For all sponsorship enquiries please contact us at firstname.lastname@example.org